Defining drug/drug class refractoriness vs lines of therapy in relapsed/refractory multiple myeloma
2023 · Blood Cancer Journal · 16 citations
https://doi.org/10.1038/s41408-023-00785-y
U
Utkarsh Goel
Cleveland Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
64
Papers
270
Citations
9
h-index
9
i10-index
Utkarsh Goel is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Protein Degradation and Inhibitors & CAR-T cell therapy research. The author has an h-index of 9, co-authored 55 publications.
ORCID: 0000-0003-1663-0325Papers by this author
worksOutcomes of teclistamab in patients with relapsed/refractory multiple myeloma with prior exposure to BCMA-directed therapy: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium
2025 · Blood Cancer Journal · 7 citations
https://doi.org/10.1038/s41408-025-01314-9
Impact of the time interval between end of induction and autologous hematopoietic transplantation in newly diagnosed patients with multiple myeloma
2022 · Bone Marrow Transplantation · 5 citations
https://doi.org/10.1038/s41409-022-01835-y
Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: 14‐Year Experience of an Academic Center
2025 · Hematological Oncology · 3 citations
https://doi.org/10.1002/hon.70082
MM-1268: Health Care Contact Days After Standard of Care (SOC) B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Relapsed/Refractory Multiple Myeloma (RRMM)
2025 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(25)02707-7
Functional High-Risk (FHR) Phenotype Predicts Poor Survival in Multiple Myeloma (MM) Independent of Frontline Treatment: A Secondary CIBMTR Analysis
2025 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(25)03457-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat